Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)
18.75
-0.34 (-1.78%)
Oct 27, 2025, 11:30 AM CST
SHA:600161 Market Cap
SHA:600161 has a market cap or net worth of 37.75 billion as of October 24, 2025. Its market cap has decreased by -6.88% in one year.
Market Cap
37.75B
Enterprise Value
39.57B
Revenue
6.42B
Ranking
n/a
PE Ratio
28.94
Stock Price
18.75
Market Cap Chart
Since March 8, 2000, SHA:600161's market cap has increased from 3.95B to 37.75B, an increase of 856.24%. That is a compound annual growth rate of 9.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 37.75B | -6.88% |
| Dec 31, 2024 | 40.54B | -20.49% |
| Dec 29, 2023 | 50.98B | 30.38% |
| Dec 30, 2022 | 39.10B | -1.67% |
| Dec 31, 2021 | 39.77B | -23.98% |
| Dec 31, 2020 | 52.31B | 79.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 435.31B |
| WuXi AppTec | 306.37B |
| Shenzhen Mindray Bio-Medical Electronics | 268.24B |
| Sichuan Biokin Pharmaceutical | 145.00B |
| Shanghai United Imaging Healthcare | 114.80B |
| Aier Eye Hospital Group | 114.06B |
| Zhangzhou Pientzehuang Pharmaceutical., | 109.03B |
| Yunnan Baiyao Group Co.,Ltd | 100.94B |